Skip to main content
Top
Published in:

13-11-2024 | Human Immunodeficiency Virus | Original Paper

Persistence With Human Immunodeficiency Virus Pre-exposure Prophylaxis in an Active-Duty Military Population

Authors: Jacob T. Colver, Joseph M. Yabes Jr., Joseph E. Marcus

Published in: AIDS and Behavior | Issue 2/2025

Login to get access

Abstract

There is limited data on Human Immunodeficiency Virus Pre-exposure Prophylaxis (PrEP) use and persistence in the military. Despite universal access to care, there is concern that PrEP persistence may be lower in military populations due to logistical challenges and perceived stigma. This study evaluated the persistence rates as well as reasons for PrEP discontinuation in a military cohort. This study evaluated all active-duty service members who received PrEP between 2020 and 2022 at a large military infectious diseases clinic. All charts were examined to determine patient characteristics. Patients who discontinued PrEP were contacted to determine the reason for discontinuation and invited to restart PrEP. In total, 112 service members received PrEP during the study period. The cohort was predominantly male (99%) with a median age 30 [IQR: 26–34] and a median of 2 years [IQR: 0–3] receiving PrEP. The most common indication was multiple sexual partners with less than 100% condom use (88%). At the end of the study, most (79%) patients were still receiving PrEP including 33 (37%) at other facilities. Of the twenty-four service members who were no longer receiving PrEP, 18 (75%), were able to be contacted. No patients contacted were interested in restarting PrEP. In this cohort with universal access to care, PrEP persistence rates were greater than seen in other populations. While the most common reason for discontinuation was changes in sexual behavior, systemic factors still contributed to PrEP discontinuation. Future studies should elucidate the challenges to PrEP care in the military.
Literature
6.
go back to reference Mancuso JD, Ahmed AE. Coverage of HIV pre-exposure prophylaxis (PrEP) within the active duty U.S. military, 2023. MSMR. 2024;31(3):13–16. Mancuso JD, Ahmed AE. Coverage of HIV pre-exposure prophylaxis (PrEP) within the active duty U.S. military, 2023. MSMR. 2024;31(3):13–16.
9.
go back to reference Beltran RM, Schuyler AC, Blair CS, et al. That’s kind of like the big struggle right now is can we get PrEP? Facilitators and Barriers to PrEP Uptake Among Active Duty Gay and Bisexual Men. Sexuality Res Social Policy. 2021;20:413–25.CrossRef Beltran RM, Schuyler AC, Blair CS, et al. That’s kind of like the big struggle right now is can we get PrEP? Facilitators and Barriers to PrEP Uptake Among Active Duty Gay and Bisexual Men. Sexuality Res Social Policy. 2021;20:413–25.CrossRef
13.
go back to reference Platt L, Shebl FM, Qian Y, et al. Pre-exposure Prophylaxis Persistence at a Diverse Sexual Health Clinic: Comparison of the pre-COVID-19 era to the COVID-19 era. AIDS Behav. 2023;27(8):2731–40.CrossRefPubMedPubMedCentral Platt L, Shebl FM, Qian Y, et al. Pre-exposure Prophylaxis Persistence at a Diverse Sexual Health Clinic: Comparison of the pre-COVID-19 era to the COVID-19 era. AIDS Behav. 2023;27(8):2731–40.CrossRefPubMedPubMedCentral
22.
go back to reference Songtaweesin WN, Kawichai S, Phanuphak N, et al. Youth-friendly services and a mobile phone application to promote adherence to pre‐exposure prophylaxis among adolescent men who have sex with men and transgender women at‐risk for HIV in Thailand: a randomized control trial. J Int AIDS Soc. 2020;23(S5). https://doi.org/10.1002/jia2.25564. Songtaweesin WN, Kawichai S, Phanuphak N, et al. Youth-friendly services and a mobile phone application to promote adherence to pre‐exposure prophylaxis among adolescent men who have sex with men and transgender women at‐risk for HIV in Thailand: a randomized control trial. J Int AIDS Soc. 2020;23(S5). https://​doi.​org/​10.​1002/​jia2.​25564.
25.
go back to reference McMahan VM, Atkins DL, Buckler S, et al. Challenges recruiting and retaining people at risk for HIV who use methamphetamine in a randomized PrEP adherence trial in Seattle, WA. Int J STD AIDS. 2024;0:0. McMahan VM, Atkins DL, Buckler S, et al. Challenges recruiting and retaining people at risk for HIV who use methamphetamine in a randomized PrEP adherence trial in Seattle, WA. Int J STD AIDS. 2024;0:0.
26.
Metadata
Title
Persistence With Human Immunodeficiency Virus Pre-exposure Prophylaxis in an Active-Duty Military Population
Authors
Jacob T. Colver
Joseph M. Yabes Jr.
Joseph E. Marcus
Publication date
13-11-2024
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2025
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-024-04543-4

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video